focus -WSS

focus

author：knowledge 2025-10-02 18:50:12 - browse：234

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Profiling embryos to choose those with higher IQs is almost a reality

focus

WSS

Allen Institute goes after foundational questions, CEO Costa says

JPM pitch from hospitals? Revenue streams outside of patient care

Drug cartel violence flares in western Mexico after vigilante leader's killing

Hospital chaplains balance Covid safety with patients’ spiritual needs

Prescription digital therapeutics are key to pharma’s future

Does Paxlovid work in people vaccinated against Covid

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

How one medical school became remarkably diverse

STAT Virtual Event: JPM Recap, Live!

Walensky prepares to leave CDC — and Congress — behind

Security flaws in third

DIEP, the 'gold standard' of breast reconstruction, is under threat

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

How to save PrEP access — and even expand it

Being 'nonadherent' patient made me a more empathetic doctor

Psychedelics group wrestles with new pharma identity

Hubble vs. James Webb telescope images: See the difference

hotspot

Medicare Advantage overpayments discussion gets experts fired up

UpToDate has a racism problem: Dr. Stanley Goldfarb

FDA early review: GLP

Medicare Advantage overpayments discussion gets experts fired up

Study suggests new cause of Down syndrome: cells linked to aging

Skip the lead apron during X

focus

focus

knowledge

focus